Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...

Artiva Biotherapeutics’ CEO Fred Aslan, MD, identifies data points the company is prioritizing to demonstrate that results from certain trials will translate to similar efficacy across a range of ...

Cellares’ Cell Shuttle performed all unit operations in an automated manner, including cell isolation, enrichment, gene ...

and Sjoegren's syndrome], rapcabtagene autoleucel [systemic scleroderma, myositis, and relapsing multiple sclerosis], and remibrutinib [chronic spontaneous urticaria and hidradenitis suppurativa].

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), has concluded the Technology Adoption ...

Your skin holds vital clues about your health. From thyroid issues to heart problems, discover what your skin is trying to ...

The Technology Adoption Program successfully tested the ability of the Bridgewater Smart Factory to automate, lower costs and ...

including scleroderma, thyroiditis, primary biliary cirrhosis, Sjogren syndrome, systemic lupus, dermatomyositis, and neonatal lupus. Iatrogenic chimerism has been investigated in transplantation ...

Kris Aquino has opened up about her breakup with the doctor she was dating in 2024. She took to Instagram to share her latest health update, in which she said she could not walk after trying ...

Exacerbations or as maintenance therapy in select cases of systemic lupus erythematosus and systemic dermatomyositis (polymyositis ... in patients who have any of the following conditions: scleroderma ...